Open AccessSpecial considerations for consent in immuno-oncology - Medic LAWgic recommendations
Author(s) -
Purvish M. Parikh,
Karishma Jhaveri,
Ankur Bahl,
Vineet Talwar,
Pritish Gandhi,
Randeep Singh,
Sudeep Shreshta,
TP Sahoo
Publication year - 2019
Publication title -
international journal of molecular and immuno oncology
Language(s) - English
Resource type - Journals
eISSN - 2836-3779
pISSN - 2456-3994
DOI - 10.25259/ijmio-3-2019
Subject(s) - test (biology) , health care , class (philosophy) , medicine , process (computing) , medical education , engineering ethics , computer science , engineering , political science , paleontology , artificial intelligence , law , biology , operating system
Novel immuno-oncology medications are a new addition to the armamentarium in the fight against cancer. This new class of drugs have unique toxicities whose understanding is constantly evolving. Today more is published in scientific literature every year then we can test in our lifetime. Hence we need to take advantage of existing technology to improve the experience of the healthcare team as well as the patients and care givers while going through available literature and information. This will improve understanding and empower the patients to participate actively in the decision making process. This manuscript is an initiative to achieve this objective.